IL
Ipca Laboratories UK Ltd
Has won 5 UK public-sector contracts worth £1.9m across 2 buyers, primarily NHS England.
Active contracts
4
no new awards in 30d
Contracted (12m)
—
no data
Public buyers
2
stable this month
Top buyer share
100%
NHS England
Buyer concentration
Each block sized by share of total award value. A dominant block signals dependency on one buyer.
Severe concentration. Top buyer alone = 100% of revenue.
NHS England
£1.9m
100%The NHS Commissioning Board (operating under the name of NHS England)
—
0%Contracts won · 5 total · 4 active · 1 expired
Every contract award published under the Procurement Act.
| Title | Buyer | Award type | Value | Awarded | Status |
|---|---|---|---|---|---|
| NHS National Generics Pharmaceuticals Transition 2023_1 | NHS England | Shared contract | £1.9m lot total · 30 suppliers | 05 May 2023 | expired |
| NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) | NHS England | Shared contract | £0.02 lot total · 63 suppliers | 04 Mar 2024 | active |
| NHS National Generic Pharmaceuticals Wave 14c | NHS England | Direct contract | — | — | active |
| NHS National Generics Pharmaceuticals Transition 2023_1 | NHS England | Direct contract | — | — | active |
| NHS National Generic Pharmaceuticals Wave 13 | The NHS Commissioning Board (operating under the name of NHS England) | Direct contract | — | — | active |